Cardiac Monitoring of Post-Operative Cancer Patients Experiencing Atrial Fibrillation

Terminated

• Conditions: Fibrillation; Post-Operative Cancer Patients Experiencing Atrial

• Registration Number: NCT01253590
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to assess whether it is possible and acceptable to monitor patients at a distance who experience a condition called atrial fibrillation after their cancer surgery. Some patients have no other clinical reason for staying in the hospital after cancer surgery except in order to control their heart rhythm. Being able to send these patients home earlier and monitor them at a distance from their home can be good for their quick recovery. Studies have shown greater quality of life and patient satisfaction when patients are monitored at a distance for conditions like atrial fibrillation, however cancer patients have not been studied.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-12
• Study First Submitted: 2010-12-02
• Study First Submitted QC: 2010-12-02
• Study First Posted: 2010-12-03
• Primary Completion: 2011-11
• Study Completion: 2011-11
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-04
• Last Update Posted: 2015-03-06

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• Post-Operative cancer patients experiencing atrial fibrillation and otherwise clinically ready to be discharged.
• Must attend two outpatient visits at MSKCC's cardiology practice during the study period, as specified by the participant's Attending.
• Must be older than 21 years of age.

Exclusion Criteria

• Non-English speaking patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assess the feasibility and acceptance of continuous remote cardiac monitoring	4 to 6 weeks	In post-operative patients with respect to recurrence of post-operative atrial fibrillation upon discharge.

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States